Medicine & Life Sciences
Nicotinic Receptors
100%
Positron-Emission Tomography
57%
Brain
38%
3-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxide
28%
Ligands
28%
A 85380
27%
Cannabinoid Receptors
25%
Radioactivity
21%
epibatidine
19%
5-iodo-3-(2-azetidinylmethoxy)pyridine
18%
pyridine
18%
Cannabinoid Receptor CB1
16%
7-azabicyclo(2.2.1)heptane
16%
2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine
14%
Neuroimaging
14%
4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
14%
2-(6-fluoro-2,3'-bipyridin-5'-yl)-7-methyl-7-azabicyclo(2.2.1)heptane
12%
Papio
12%
6-fluoro-3-(2-azetidinylmethoxy)pyridine
11%
Thalamus
10%
2-(2-iodo-5-pyridyl)-7-azabicyclo(2.2.1)heptane
10%
Halogenation
10%
cryptating agent 222
9%
Epoxide Hydrolases
9%
Kinetics
9%
Cannabinoids
8%
2-(2-fluoro-5-pyridyl)-7-azabicyclo(2.2.1)heptane
8%
Single-Photon Emission-Computed Tomography
8%
iomazenil
8%
2-fluoro-3-(2-azetidinylmethoxy)pyridine
8%
N-nitrosoiminodiacetic acid
7%
Schizophrenia
7%
Research Subjects
7%
In Vitro Techniques
7%
pyrazole
7%
methyl iodide
6%
Healthy Volunteers
6%
Rimonabant
5%
furan
5%
Pharmacology
5%
dibenzothiophene
5%
Macrophage Colony-Stimulating Factor
5%
cytisine
5%
Autoradiography
5%
Microglia
5%
Chemical Compounds
Acetylcholine
50%
Radioligand
40%
Positron
36%
Radiochemical Yield
19%
Radioactivity
18%
Cannabinoid
18%
Ligand
14%
Pyridine
13%
Heptane
11%
Kd
10%
Lipophilicity
9%
Epibatidine
9%
Fluorination
5%
Purity
5%